Rapport Therapeutics, Inc. (RAPP) — SC 13D Filings
All SC 13D filings from Rapport Therapeutics, Inc.. Browse 1 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (1)
-
Sofinnova Discloses 15.4% Stake in Rapport Therapeutics
— Jun 14, 2024 Risk: medium
On June 14, 2024, Sofinnova Venture Partners XI, L.P. and its affiliates, including Dr. James I. Healy and Dr. Maha Katabi, reported a beneficial ownership of 1
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX